152 related articles for article (PubMed ID: 1668824)
1. Correlation between plasma levels of ACTH and cortisol in basal states and during the CRH test in normal subjects and patients with hypothalamo-pituitary disorders.
Bando H; Zhang CY; Takada Y; Takahashi H; Yamasaki R; Saito S
Tokushima J Exp Med; 1991 Dec; 38(3-4):61-9. PubMed ID: 1668824
[TBL] [Abstract][Full Text] [Related]
2. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
[TBL] [Abstract][Full Text] [Related]
3. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
[TBL] [Abstract][Full Text] [Related]
4. Corticotropin-releasing factor test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders.
Nakahara M; Shibasaki T; Shizume K; Kiyosawa Y; Odagiri E; Suda T; Yamaguchi H; Tsushima T; Demura H; Maeda T
J Clin Endocrinol Metab; 1983 Nov; 57(5):963-8. PubMed ID: 6311867
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
Robaczyk MG
Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
[TBL] [Abstract][Full Text] [Related]
6. CRH in Cushing's syndrome.
Müller OA; Stalla GK; von Werder K
Horm Metab Res Suppl; 1987; 16():51-8. PubMed ID: 2832289
[TBL] [Abstract][Full Text] [Related]
7. Plasma adrenocorticotropin and cortisol responses to ovine corticotropin-releasing factor in patients with adrenocortical insufficiency due to hypothalamic and pituitary disorders.
Tsukada T; Nakai Y; Koh T; Tsujii S; Inada M; Nishikawa M; Shinoda H; Kawai I; Takezawa N; Imura H
J Clin Endocrinol Metab; 1984 Apr; 58(4):758-60. PubMed ID: 6321536
[TBL] [Abstract][Full Text] [Related]
8. CRH and lysine-vasopressin stimulation tests in the diagnosis of hypoadrenalism secondary to hypothalamic or pituitary disorders.
Cantalamessa L; Catania A; Baldini M; Orsatti A; Motta P; Peracchi G
Horm Metab Res; 1990 Jul; 22(7):389-93. PubMed ID: 2169450
[TBL] [Abstract][Full Text] [Related]
9. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
Gold PW; Kling MA; Khan I; Calabrese JR; Kalogeras K; Post RM; Avgerinos PC; Loriaux DL; Chrousos GP
Adv Biochem Psychopharmacol; 1987; 43():183-200. PubMed ID: 3035886
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactive corticotropin-releasing factor in human plasma.
Suda T; Tomori N; Yajima F; Sumitomo T; Nakagami Y; Ushiyama T; Demura H; Shizume K
J Clin Invest; 1985 Nov; 76(5):2026-9. PubMed ID: 2997301
[TBL] [Abstract][Full Text] [Related]
11. Effect of metyrapone pretreatment on adrenocorticotropin secretion induced by corticotropin-releasing hormone in normal subjects and patients with Cushing's disease.
Totani Y; Niinomi M; Takatsuki K; Oiso Y; Tomita A
J Clin Endocrinol Metab; 1990 Mar; 70(3):798-803. PubMed ID: 2155255
[TBL] [Abstract][Full Text] [Related]
12. The corticotropin-releasing hormone test in the diagnosis of ACTH-dependent Cushing's syndrome: a reappraisal.
Pecori Giraldi F; Invitti C; Cavagnini F;
Clin Endocrinol (Oxf); 2001 May; 54(5):601-7. PubMed ID: 11380490
[TBL] [Abstract][Full Text] [Related]
13. Corticotrophin releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitary.
Lytras N; Grossman A; Perry L; Tomlin S; Wass JA; Coy DH; Schally AV; Rees LH; Besser GM
Clin Endocrinol (Oxf); 1984 Jan; 20(1):71-84. PubMed ID: 6319053
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
Trainer PJ; Faria M; Newell-Price J; Browne P; Kopelman P; Coy DH; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1995 Feb; 80(2):412-7. PubMed ID: 7852498
[TBL] [Abstract][Full Text] [Related]
15. Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain.
Griep EN; Boersma JW; Lentjes EG; Prins AP; van der Korst JK; de Kloet ER
J Rheumatol; 1998 Jul; 25(7):1374-81. PubMed ID: 9676772
[TBL] [Abstract][Full Text] [Related]
16. Corticotropin-releasing hormone stimulation test before and after transsphenoidal selective microadenomectomy in 30 patients with Cushing's disease.
Schrell U; Fahlbusch R; Buchfelder M; Riedl S; Stalla GK; Müller OA
J Clin Endocrinol Metab; 1987 Jun; 64(6):1150-9. PubMed ID: 3033006
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
Kling MA; Roy A; Doran AR; Calabrese JR; Rubinow DR; Whitfield HJ; May C; Post RM; Chrousos GP; Gold PW
J Clin Endocrinol Metab; 1991 Feb; 72(2):260-71. PubMed ID: 1846869
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactive corticotropin-releasing hormone present in human plasma may be derived from both hypothalamic and extrahypothalamic sources.
Sasaki A; Sato S; Murakami O; Go M; Inoue M; Shimizu Y; Hanew K; Andoh N; Sato I; Sasano N
J Clin Endocrinol Metab; 1987 Jul; 65(1):176-82. PubMed ID: 3294879
[TBL] [Abstract][Full Text] [Related]
19. Responsiveness of the hypophyseal-adrenocortical axis to corticotropin-releasing factor in pituitary-dependent Cushing's disease.
Pieters GF; Hermus AR; Smals AG; Bartelink AK; Benraad TJ; Kloppenborg PW
J Clin Endocrinol Metab; 1983 Sep; 57(3):513-6. PubMed ID: 6308029
[TBL] [Abstract][Full Text] [Related]
20. Human corticotropin-releasing hormone test in normal subjects and patients with hypothalamic, pituitary or adrenocortical disorders.
Fukata J; Nakai Y; Imura H; Abe K; Aono T; Demura H; Fujita T; Hibi I; Ibayashi H; Igarashi M
Endocrinol Jpn; 1988 Jun; 35(3):491-502. PubMed ID: 2848692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
